期刊
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
卷 270, 期 6, 页码 1909-1915出版社
SPRINGER
DOI: 10.1007/s00405-012-2290-2
关键词
Head and neck cancer; Concurrent chemoradiation; Risk factors; Early death; Malnutrition
Unexpected fatal events in patients with head and neck cancers undergoing concurrent chemoradiation therapy are a clinical concern. Malnutrition, which is reported frequently in head and neck cancer patients, are associated with immunity derangement. The purpose of this study was to identify risk factors for early death of patients undergoing chemoradiation. We retrospectively analyzed the records of 194 stage III, IVA, and IVB head and neck cancer patients who were treated with chemoradiation between 2007 and 2009. We defined early death as death while receiving chemoradiation or within 60 days of treatment completion. Risk factors for early death were tested using univariate and multivariate analyses. Fourteen patients (7.2 %) experienced early death, 78.6 % of whom died of infection. Univariate analysis revealed significant correlations between early death and several pretreatment variables, including Eastern Cooperative Oncology Group performance status (PS) > 1, hemoglobin < 10 g/dL, albumin < 3 g/dL, body mass index (BMI) < 19 kg/m(2), and peripheral blood total lymphocyte count < 700/mu L. Multivariate analysis showed that PS > 1, BMI < 19 kg/m(2), and peripheral blood total lymphocyte count < 700/mu L were independent variables associated with early death. Poor performance status and malnutrition before chemoradiation independently predict early death in locally advanced head and neck cancer patients undergoing chemoradiation. Cautious management of head and neck cancer patients with these risk factors is required throughout chemoradiation period.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据